Den europeiske union -
norsk -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromuskulær blokkade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
Norge -
norsk -
Statens legemiddelverk
heparin leo 5000 ie/ ml
leo pharma - heparinnatrium - injeksjonsvæske, oppløsning - 5000 ie/ ml
Norge -
norsk -
Statens legemiddelverk
sugammadex teva 100 mg/ ml
teva b.v. - sugammadeksnatrium - injeksjonsvæske, oppløsning - 100 mg/ ml
Norge -
norsk -
Statens legemiddelverk
etalpha 2 mikrog/ ml
leo pharma - alfakalsidol - injeksjonsvæske, oppløsning - 2 mikrog/ ml
Norge -
norsk -
Statens legemiddelverk
etalpha 2 mikrog/ ml
cheplapharm arzneimittel gmbh - alfakalsidol - dråper, oppløsning - 2 mikrog/ ml
Norge -
norsk -
Statens legemiddelverk
etalpha 0.25 mikrog
cheplapharm arzneimittel gmbh - alfakalsidol - kapsel, myk - 0.25 mikrog
Norge -
norsk -
Statens legemiddelverk
etalpha 0.5 mikrog
cheplapharm arzneimittel gmbh - alfakalsidol - kapsel, myk - 0.5 mikrog
Den europeiske union -
norsk -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Den europeiske union -
norsk -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversering av nevromuskulær blokade indusert av rocuronium eller vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Den europeiske union -
norsk -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.